OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes
In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI
Animal Problems May Stop NIC Construction Grant To city Of Hope
OSCC Groups Send Four Concepts To NCI Board
DCPC BSC Committee Okay Three Concepts
ACS Division Help Fund Some CIS Offices
ELM’s CHOP-DS Aims For 15% Of Patients
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
